Brief: Clinical Laserthermia Systems Q2 Loss After Financial Items Narrows To SEK 17 Mln
Aug 12 (Reuters) - Clinical Laserthermia Systems AB
CLSRb.ST :
* CLINICAL LASERTHERMIA SYSTEMS AB PUBLISHES HALF-YEAR
REPORT
JANUARY - JUNE 2022
* Q2 NET SALES TOTALLED SEK 381,000 (SEK 0,000)
* Q2 LOSS AFTER FINANCIAL ITEMS AMOUNTED TO SEK -17,015,000
(LOSS
SEK 23,127,000)
Source text for Eikon: ID:nWkr9PzyPP
Further company coverage: CLSRb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Clinical Laserthermia Systems AB
See all newsBrief: CLS Enters Research Agreement With U.S. National Cancer Institute
Sweden's CLS Q1 sales fall 72% after partner talks
Brief: Clinical Laserthermia Systems Q1 EBIT Sek 1.7 Mln
Brief: CLS Receives Order Worth SEK 23 Mln For Prism Business
Brief: CLS Expects To Achieve Positive Cash Flow From Q4 2026 To Q1 2028